No price series to chart for TRLV.
TRLV is not in the screener universe; fundamentals are unavailable.
No price history for TRLV — it is outside the redistributable backbone (BYOK data required), so price statistics are unavailable.
No return history for TRLV, so risk analytics are unavailable.
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | $4.58B | — |
| TLRY | Tilray Brands, Inc. | $3.55B | — |
| CRON | Cronos Group Inc. | $1.07B | — |
| USNA | USANA HEALTH SCIENCES INC | $418.6M | 39.1 |
| CGC | Canopy Growth Corp | $375.5M | — |
| SNDL | SNDL Inc. | $316.0M | — |
| NAGE | Niagen Bioscience, Inc. | $256.5M | 16.1 |
| CRLBF | Cresco Labs Inc. | $225.4M | — |
| ACB | AURORA CANNABIS INC | $153.0M | — |
| FTLF | FITLIFE BRANDS, INC. | $96.3M | 16.3 |
| AAWH | Ascend Wellness Holdings, Inc. | $81.2M | — |
| JUSHF | Jushi Holdings Inc. | $75.9M | — |